Health ❯ Healthcare ❯ Treatment Options
Surgery Stem Cell Transplantation Preventative Care Prosthetics Radiation Therapy Pediatric Oncology Patient Stories Patient Experience Palliative Care Immunotherapy
The Phase 3 result positions the TROP2‑targeting ADC for regulatory filings, potentially shifting first‑line care for patients who cannot receive immunotherapy.
